Ayala Pharmaceuticals Funding: $47M Raised, Series B (2019)
Ayala Pharmaceuticals is based in Rehovot, Israel. It has raised $47M in total funding. Latest round: Series B.
Ayala Pharmaceuticals funding overview
Ayala Pharmaceuticals is based in Rehovot, Israel. Ayala Pharmaceuticals has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2019. The round record for Ayala Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include Novartis, SBI JI Innovation Fund, Israel Biotech Fund, aMoon, Harel Insurance & Finance Group. 5 distinct backers are named across the disclosed rounds.
Ayala Pharmaceuticals at a glance
Total raised
$47M
Latest round
Series B
Latest round date
May 2019
Headquarters
Rehovot, Israel
Notable investors
Novartis, SBI JI Innovation Fund, Israel Biotech Fund, aMoon, Harel Insurance & Finance Group
Frequently asked about Ayala Pharmaceuticals funding
How much has Ayala Pharmaceuticals raised?
Ayala Pharmaceuticals has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Ayala Pharmaceuticals?
Novartis, SBI JI Innovation Fund, Israel Biotech Fund, aMoon, Harel Insurance & Finance Group are named among the investors backing Ayala Pharmaceuticals.
What was the latest Ayala Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in May 2019.
Where is Ayala Pharmaceuticals based?
Ayala Pharmaceuticals is based in Rehovot, Israel.
When did Ayala Pharmaceuticals last raise?
The last disclosed Ayala Pharmaceuticals round closed in May 2019 at Series B.
Every Ayala Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Rehovot at a similar stage.
